NCT01755195 2024-01-03
Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC